Abstract:Background: Futile recanalization affects more than half of acute ischemic stroke (AIS) patients. Neutrophil extracellular traps (NETs) are a major factor of microvascular hypoperfusion after stroke. Deoxyribonuclease I (DNase) targeting NETs exhibited a neuroprotective effect in young mice with AIS. This study explored a novel direct intra-arterial administration of DNase therapy and its effect in aged mice with AIS. Method: AIS was induced in aged C57BL/6 mice followed by reperfusion and immediate, intra-arterial DNase administration via the internal carotid artery. Cerebral blood flow, neurological function, cerebral infarct volume, and NET markers were examined. Results: Direct intra-arterial DNase therapy significantly increased cerebral blood flow, reduced neurological deficit scores, increased the latency to fall in wire hang test, reduced cerebral infarct volume, and decreased neutrophil and NET count in both the parenchyma and micro vessels in aged mice with AIS compared with age-matched, vehicle controls. Conclusion: Our data is the first to demonstrate that successful, direct intra-arterial DNase therapy provides more efficient cerebral reperfusion and better outcomes after recanalization during the treatment of large vessel occlusion in aged mice. This study provides evidence for the potential clinical application of catheter delivered intra-arterial DNase therapy post-recanalization.

What problem does this paper attempt to address?

This paper attempts to solve a key problem in the treatment of acute ischemic stroke (AIS), namely, insufficient microcirculation perfusion after recanalization (futile recanalization). Specifically, the study focuses on the role of neutrophil extracellular traps (NETs) in microvascular hypoperfusion after stroke. NETs are one of the main factors leading to microvascular obstruction, which affects blood flow after recanalization and, in turn, the patient's recovery. To improve this situation, the research team explored a new treatment method, that is, by directly injecting deoxyribonuclease I (DNase) intra - arterially to break down NETs, thereby reducing microvascular obstruction, increasing cerebral blood flow, and improving stroke prognosis in an aged mouse model. The main goal of the study was to evaluate the effectiveness and potential clinical application value of this new method. ### Research Background - **Problem Description**: More than half of acute ischemic stroke patients still have a poor prognosis after receiving recanalization treatment, mainly due to insufficient microcirculation perfusion. NETs play an important role in microvascular hypoperfusion. - **Limitations of Existing Methods**: Current treatment methods such as endovascular thrombolysis (EVT) can successfully recanalize large vessels, but the reperfusion effect of microvessels is not good, resulting in the phenomenon of "futile recanalization". - **Mechanism of Action of DNase**: DNase can reduce microvascular obstruction and improve cerebral blood flow by breaking down NETs. ### Research Purposes - **Verify the Effectiveness of the New Method**: By directly injecting DNase intra - arterially, evaluate its effects on cerebral blood flow, neurological function recovery, infarct volume, and NETs burden after stroke in an aged mouse model. - **Explore the Potential for Clinical Application**: Provide evidence to support the future clinical use of catheter - delivered intra - arterial DNase therapy, especially in recanalization treatment after large - vessel occlusion. ### Main Findings - **Improve Cerebral Blood Flow**: Direct intra - arterial injection of DNase significantly increased cerebral blood flow, especially in the early stage after reperfusion. - **Improve Neurological Function**: Mice in the DNase treatment group showed better neurological function recovery, such as reduced neurological deficit scores and increased duration in the wire - hanging test. - **Reduce Infarct Volume**: DNase treatment significantly reduced the volume of cerebral infarction. - **Reduce NETs Burden**: DNase treatment significantly reduced the number of neutrophils and NETs in the brain parenchyma and microvessels. ### Conclusion This study has for the first time demonstrated that direct intra - arterial injection of DNase can more effectively improve cerebral blood flow after reperfusion and reduce NETs burden, thereby improving stroke prognosis in an aged mouse model. These results provide strong support for the future clinical application of catheter - delivered intra - arterial DNase therapy.

Intra-arterial Deoxyribonuclease therapy improves stroke outcomes in aged mice

Inhibiting the Na+/H+ Exchanger Reduces Reperfusion Injury: a Small Animal MRI Study.

Abstract WMP111: Intra-Arterial Administration of Cerebral Endothelial Cell Derived Small Extracellular Vesicles Reduces Neurovascular Damage and Improves Neurological Outcome After Acute Ischemia in the Aged Rat

Abstract TP102: Hyperexpression of Adiponectin Improves Long-term Stroke Outcome in Young and Aged Mice

Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids.

Reduced Ischemic Injury After Stroke in Mice by Angiogenic Gene Delivery Via Ultrasound-Targeted Microbubble Destruction

Intra-arterial neuroprotective therapy as an adjunct to endovascular intervention in acute ischemic stroke: A review of the literature and future directions

Abstract WP94: Delayed SDF-1 Hyperexpression Promotes Neural Stem Cell Migration and Maturation Without Increasing Inflammation after Ischemic Stroke in Mice

Postacute Stromal Cell–Derived Factor-1α Expression Promotes Neurovascular Recovery in Ischemic Mice

Neural precursor cell delivery induces acute post-ischemic cerebroprotection, but fails to promote long-term stroke recovery in hyperlipidemic mice due to mechanisms that include pro-inflammatory responses associated with brain hemorrhages

Vascular protection and regenerative effects of intranasal DL-3-N-butylphthalide treatment after ischaemic stroke in mice

Early DNase-I therapy delays secondary brain damage after traumatic brain injury in adult mice

Early transcriptional changes in neutrophil-mediated processes following recanalization after ischemic stroke

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke

Influence of Thrombolysis on the Safety and Efficacy of Blocking Platelet Adhesion or Secretory Activity in Acute Ischemic Stroke in Mice

Neurovascular Unit Protection From Cerebral Ischemia–Reperfusion Injury by Radical-Containing Nanoparticles in Mice

Neuroprotection for ischemic stroke in the endovascular era: A brief report on the future of intra-arterial therapy

Abstract TP311: Preclinical Replication Study of Psd-95 Inhibitor NA-1

Hypoxia-Inducible Factor 1α and 2α Have Beneficial Effects in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Aged Rats

Abstract TP219: Rns60 Brain Protection In Mouse Ischemic Stroke Mitigates Plasma Tau And Cortical Microvascular Perfusion

The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.